Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058.

Status:
Completed

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

The purpose of this study is to to assess the safety and tolerability of BIA 5 1058 after single and multiple oral doses

Phase 1

Bial - Portela C S.A.

Zamicastat